{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:39:56Z","timestamp":1792708796398,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/nrneph.2016.147","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T11:17:16Z","timestamp":1476703036000},"page":"768-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":192,"title":["Minimal change disease and idiopathic FSGS: manifestations of the same disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Rutger J.","family":"Maas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen K.","family":"Deegens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"BFnrneph2016147_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/B978-0-323-05876-6.00017-4","volume-title":"Comprehensive Clinical Nephrology","author":"PD Mason","year":"2010","unstructured":"Mason, P. D. & Hoyer, P. F. in Comprehensive Clinical Nephrology (ed. Floege, J.) 218\u2013227 (Elsevier, 2010)."},{"key":"BFnrneph2016147_CR2","first-page":"229","volume-title":"Comprehensive Clinical Nephrology","author":"GB Appel","year":"2010","unstructured":"Appel, G. B. & D'Agati, V. in Comprehensive Clinical Nephrology (ed. Floege, J.) 229\u2013240 (Elsevier, 2010)."},{"key":"BFnrneph2016147_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo, A. B. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat. Rev. Nephrol. 11, 76\u201387 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2016147_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S0272-6386(12)70349-9","volume":"22","author":"MM Schwartz","year":"1993","unstructured":"Schwartz, M. M. & Korbet, S. M. Primary focal and segmental glomerulosclerosis: pathology, histological variants, and pathogenesis. Am. J. Kidney Dis. 22, 874\u2013883 (1993).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D'Agati","year":"2004","unstructured":"D'Agati, V. D., Fogo, A. B., Bruijn, J. A. & Jennette, J. C. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am. J. Kidney Dis. 43, 368\u2013382 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0272-6386(89)80001-0","volume":"13","author":"H Rennke","year":"1989","unstructured":"Rennke, H. & Klein, P. S. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am. J. Kidney Dis. 13, 443\u2013456 (1989).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR7","first-page":"3","volume":"66","author":"JK Deegens","year":"2008","unstructured":"Deegens, J. K., Steenbergen, E. J. & Wetzels, J. F. Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth. J. Med. 66, 3\u201312 (2008).","journal-title":"Neth. J. Med."},{"key":"BFnrneph2016147_CR8","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/ki.2008.413","volume":"74","author":"JK Deegens","year":"2008","unstructured":"Deegens, J. K. et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int. 74, 1568\u20131576 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR9","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0140-6736(70)91905-7","volume":"760","author":"J Churg","year":"1970","unstructured":"Churg, J., Habib, R. & White, R. H. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760, 1299\u20131302 (1970).","journal-title":"Lancet"},{"key":"BFnrneph2016147_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(70)91268-7","volume":"1","author":"RH White","year":"1970","unstructured":"White, R. H., Glasgow, E. F. & Mills, R. J. Clinicopathological study of nephrotic syndrome in childhood. Lancet 1, 1353\u20131359 (1970).","journal-title":"Lancet"},{"key":"BFnrneph2016147_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","volume":"71","author":"RC Wiggins","year":"2007","unstructured":"Wiggins, R. C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 71, 1205\u20131214 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1046\/j.1523-1755.1998.00044.x","volume":"54","author":"W Kriz","year":"1998","unstructured":"Kriz, W., Gretz, N. & Lemley, K. V. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int. 54, 687\u2013697 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR13","volume-title":"Pathologie und klinik der Nephrosen, Nephritiden und Schrumpfnieren","author":"F Munk","year":"1918","unstructured":"Munk, F. Pathologie und klinik der Nephrosen, Nephritiden und Schrumpfnieren (Urban & Schwarzenberg, 1918)."},{"key":"BFnrneph2016147_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/978-3-7091-3054-4","volume-title":"Harnorgane M\u00e4nnliche Geschlechtsorgane","author":"T Fahr","year":"1925","unstructured":"Fahr, T. in Harnorgane M\u00e4nnliche Geschlechtsorgane (ed. Fahr, T.) 156\u2013472 (Springer Vienna, 1925)."},{"key":"BFnrneph2016147_CR15","first-page":"173","volume":"100","author":"AR Rich","year":"1957","unstructured":"Rich, A. R. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull. Johns Hopkins Hosp. 100, 173\u2013186 (1957).","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"BFnrneph2016147_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0022-3476(74)80605-0","volume":"84","author":"LR Hyman","year":"1974","unstructured":"Hyman, L. R. & Burkholder, P. M. Focal sclerosing glomerulonephropathy with hyalinosis. A clinical and pathologic analysis of the disease in children. J. Pediatr. 84, 217\u2013225 (1974).","journal-title":"J. Pediatr."},{"key":"BFnrneph2016147_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/ki.1973.131","volume":"4","author":"R Habib","year":"1973","unstructured":"Habib, R. Focal glomerular sclerosis. Kidney Int. 4, 355\u2013361 (1973).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1056\/NEJM196907242810402","volume":"281","author":"JP Hayslett","year":"1969","unstructured":"Hayslett, J. P., Krassner, L. S., Bensch, K. G., Kashgarian, M. & Epstein, F. H. Progression of \u201clipoid nephrosis\u201d to renal insufficiency. N. Engl. J. Med. 281, 181\u2013187 (1969).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2016147_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000183363","volume":"39","author":"A Tejani","year":"1985","unstructured":"Tejani, A. Morphological transition in minimal change nephrotic syndrome. Nephron 39, 157\u2013159 (1985).","journal-title":"Nephron"},{"key":"BFnrneph2016147_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2369-14-47","volume":"14","author":"RJ Maas","year":"2013","unstructured":"Maas, R. J., Deegens, J. K., van den Brand, J. A., Cornelissen, E. A. & Wetzels, J. F. A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation. BMC Nephrol. 14, 47 (2013).","journal-title":"BMC Nephrol."},{"key":"BFnrneph2016147_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1432-2277.2004.tb00420.x","volume":"17","author":"JK Deegens","year":"2004","unstructured":"Deegens, J. K., Andresdottir, M. B., Croockewit, S. & Wetzels, J. F. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl. Int. 17, 151\u2013157 (2004).","journal-title":"Transpl. Int."},{"key":"BFnrneph2016147_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0272-6386(12)80381-7","volume":"23","author":"M Artero","year":"1994","unstructured":"Artero, M., Sharma, R., Savin, V. J. & Vincenti, F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomeruloclerosis. Am. J. Kidney Dis. 23, 574\u2013581 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR23","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ndt\/gfp500","volume":"25","author":"G Canaud","year":"2010","unstructured":"Canaud, G. et al. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol. Dial. Transplant. 25, 1321\u20131328 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR24","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1681\/ASN.2007121365","volume":"19","author":"DH Ijpelaar","year":"2008","unstructured":"Ijpelaar, D. H. et al. Fidelity and evolution of recurrent FSGS in renal allografts. J. Am. Soc. Nephrol. 19, 2219\u20132224 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/01.TP.0000074311.71224.20","volume":"76","author":"MA Artz","year":"2003","unstructured":"Artz, M. A., Dooper, P. M., Meuleman, E. J., van der Vliet, J. A. & Wetzels, J. F. Time course of proteinuria after living-donor kidney transplantation. Transplantation 76, 421\u2013423 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph2016147_CR26","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.2215\/CJN.10571011","volume":"7","author":"H Fatima","year":"2012","unstructured":"Fatima, H. et al. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin. J. Am. Soc. Nephrol. 7, 1852\u20131858 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR27","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1016\/j.ajpath.2014.08.007","volume":"184","author":"B Smeets","year":"2014","unstructured":"Smeets, B. et al. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. Am. J. Pathol. 184, 3239\u20133248 (2014).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2016147_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/ajkd.2003.50015","volume":"41","author":"A Dumoulin","year":"2003","unstructured":"Dumoulin, A., Hill, G. S., Montseny, J. J. & Meyrier, A. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Am. J. Kidney Dis. 41, 38\u201348 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ndt\/gfp521","volume":"25","author":"R Gupta","year":"2010","unstructured":"Gupta, R. et al. Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study. Nephrol. Dial. Transplant. 25, 444\u2013449 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM198403153101101","volume":"310","author":"TK Rao","year":"1984","unstructured":"Rao, T. K. et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310, 669\u2013673 (1984).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2016147_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00428-012-1213-3","volume":"460","author":"SM Meehan","year":"2012","unstructured":"Meehan, S. M., Kim, L. & Chang, A. A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection. Virchows Arch. 460, 429\u2013435 (2012).","journal-title":"Virchows Arch."},{"key":"BFnrneph2016147_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5414\/CNP74173","volume":"74","author":"ME Schachter","year":"2010","unstructured":"Schachter, M. E. et al. Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression. Clin. Nephrol. 74, 173\u2013181 (2010).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2016147_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1681\/ASN.2004080720","volume":"16","author":"T Matsusaka","year":"2005","unstructured":"Matsusaka, T. et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J. Am. Soc. Nephrol. 16, 1013\u20131023 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR34","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1681\/ASN.2005010055","volume":"16","author":"BL Wharram","year":"2005","unstructured":"Wharram, B. L. et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol. 16, 2941\u20132952 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3181\/00379727-89-21833","volume":"89","author":"S Frenk","year":"1955","unstructured":"Frenk, S., Antonowicz, I., Craig, J. M. & Metcoff, J. Experimental nephrotic syndrome induced in rats by aminonucleoside; renal lesions and body electrolyte composition. Proc. Soc. Exp. Biol. Med. 89, 424\u2013427 (1955).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BFnrneph2016147_CR36","first-page":"16","volume":"46","author":"T Bertani","year":"1982","unstructured":"Bertani, T. et al. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab. Invest. 46, 16\u201323 (1982).","journal-title":"Lab. Invest."},{"key":"BFnrneph2016147_CR37","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1093\/ndt\/gfg438","volume":"18","author":"B Smeets","year":"2003","unstructured":"Smeets, B. et al. Podocyte changes upon induction of albuminuria in Thy-1.1 transgenic mice. Nephrol. Dial. Transplant. 18, 2524\u20132533 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR38","first-page":"481","volume":"122","author":"JR Diamond","year":"1986","unstructured":"Diamond, J. R. & Karnovsky, M. J. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am. J. Pathol. 122, 481\u2013487 (1986).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2016147_CR39","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","volume":"60","author":"YH Kim","year":"2001","unstructured":"Kim, Y. H. et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int. 60, 957\u2013968 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR40","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1016\/S0041-1345(01)02437-X","volume":"33","author":"L Le Berre","year":"2001","unstructured":"Le Berre, L. et al. The Buffalo\/Mna rat, an animal model of FSGS recurrence after renal transplantation. Transplant. Proc. 33, 3338\u20133340 (2001).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2016147_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI0212858","volume":"109","author":"L Le Berre","year":"2002","unstructured":"Le Berre, L. et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats. J. Clin. Invest. 109, 491\u2013498 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2016147_CR42","first-page":"OR053","volume":"26","author":"R Robins","year":"2015","unstructured":"Robins, R., Baldwin, C., Aoudjit, L., Gupta, I. R. & Takano, T. The spectrum of nephrotic syndrome from minimal change disease to FSGS correlates with Rac1 activation. J. Am. Soc. Nephrol. 26, abstr. SA-OR053 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ki.2009.424","volume":"77","author":"P Mundel","year":"2010","unstructured":"Mundel, P. & Reiser, J. Proteinuria: an enzymatic disease of the podocyte? Kidney Int. 77, 571\u2013580 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR44","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1046\/j.1523-1755.1999.00362.x","volume":"55","author":"S Mentzel","year":"1999","unstructured":"Mentzel, S., van Son, J. P., Dijkman, H. B., Wetzels, J. F. & Assmann, K. J. Induction of albuminuria in mice: synergistic effect of two monoclonal antibodies directed to different domains of aminopeptidase A. Kidney Int. 55, 1335\u20131347 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1073\/pnas.35.4.194","volume":"35","author":"T Addis","year":"1949","unstructured":"Addis, T. The mechanism of proteinuria. Proc. Natl Acad. Sci. USA 35, 194\u2013198 (1949).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2016147_CR46","first-page":"64","volume":"129","author":"JJ Weening","year":"1987","unstructured":"Weening, J. J. et al. The pathophysiology of protein-overload proteinuria. Am. J. Pathol. 129, 64\u201373 (1987).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2016147_CR47","first-page":"907","volume":"74","author":"H Gelberg","year":"1996","unstructured":"Gelberg, H., Healy, L., Whiteley, H., Miller, L. A. & Vimr, E. In vivo enzymatic removal of \u03b1 2-\u21926-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. Lab. Invest. 74, 907\u2013920 (1996).","journal-title":"Lab. Invest."},{"key":"BFnrneph2016147_CR48","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser, J. et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J. Clin. Invest. 113, 1390\u20131397 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2016147_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/BF00869832","volume":"4","author":"H Trachtman","year":"1990","unstructured":"Trachtman, H., Del Pizzo, R., Valderrama, E. & Gauthier, B. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy. Pediatr. Nephrol. 4, 501\u2013504 (1990).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR50","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1681\/ASN.2005020142","volume":"16","author":"T Wada","year":"2005","unstructured":"Wada, T., Pippin, J. W., Marshall, C. B., Griffin, S. V. & Shankland, S. J. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J. Am. Soc. Nephrol. 16, 2615\u20132625 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement, L. C. et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat. Med. 17, 117\u2013122 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph2016147_CR52","doi-asserted-by":"publisher","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","volume":"296","author":"JW Pippin","year":"2009","unstructured":"Pippin, J. W. et al. Inducible rodent models of acquired podocyte diseases. Am. J. Physiol. Renal Physiol. 296, F213\u2013F229 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2016147_CR53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1523-1755.2001.059002601.x","volume":"59","author":"S Chugh","year":"2001","unstructured":"Chugh, S. et al. Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum. Kidney Int. 59, 601\u2013613 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","volume":"59","author":"SS Chugh","year":"2012","unstructured":"Chugh, S. S., Clement, L. C. & Mace, C. New insights into human minimal change disease: lessons from animal models. Am. J. Kidney Dis. 59, 284\u2013292 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR55","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","volume":"29","author":"RJ Maas","year":"2014","unstructured":"Maas, R. J., Deegens, J. K. & Wetzels, J. F. Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future. Nephrol. Dial. Transplant. 29, 2207\u20132216 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR56","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952\u2013960 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph2016147_CR57","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"ET McCarthy","year":"2010","unstructured":"McCarthy, E. T., Sharma, M. & Savin, V. J. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 5, 2115\u20132121 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ki.1991.232","volume":"40","author":"A Koyama","year":"1991","unstructured":"Koyama, A., Fujisaki, M., Kobayashi, M., Igarashi, M. & Narita, M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 40, 453\u2013460 (1991).","journal-title":"Kidney Int."},{"issue":"Suppl. 6","key":"BFnrneph2016147_CR59","first-page":"vi21","volume":"18","author":"PE Brenchley","year":"2003","unstructured":"Brenchley, P. E. Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 18 (Suppl. 6), vi21\u2013vi25 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR60","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1111\/j.1523-1755.2005.00322.x","volume":"67","author":"H Mansour","year":"2005","unstructured":"Mansour, H. et al. T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney Int. 67, 2168\u20132177 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR61","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","volume":"20","author":"WW Bakker","year":"2005","unstructured":"Bakker, W. W. et al. Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr. Nephrol. 20, 1410\u20131415 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR62","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ki.2012.32","volume":"81","author":"RJ Maas","year":"2012","unstructured":"Maas, R. J., Wetzels, J. F. & Deegens, J. K. Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int. 81, 1043\u20131044 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR63","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ki.2013.505","volume":"85","author":"B Meijers","year":"2014","unstructured":"Meijers, B. et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int. 85, 636\u2013640 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR64","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/ki.2013.544","volume":"85","author":"T Wada","year":"2014","unstructured":"Wada, T. et al. A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int. 85, 641\u2013648 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/ki.2013.546","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha, A. et al. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int. 85, 649\u2013658 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR66","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ki.2014.346","volume":"87","author":"JM Spinale","year":"2015","unstructured":"Spinale, J. M. et al. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int. 87, 564\u2013574 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub, R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2, 556\u2013560 (1974).","journal-title":"Lancet"},{"key":"BFnrneph2016147_CR68","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","volume":"24","author":"C Araya","year":"2009","unstructured":"Araya, C. et al. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr. Nephrol. 24, 1691\u20131698 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR69","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cyto.2014.12.028","volume":"72","author":"N Prasad","year":"2015","unstructured":"Prasad, N. et al. Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in Childhood Nephrotic Syndrome: a longitudinal study. Cytokine 72, 190\u2013196 (2015).","journal-title":"Cytokine"},{"key":"BFnrneph2016147_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1681\/ASN.2007111244","volume":"20","author":"L Le Berre","year":"2009","unstructured":"Le Berre, L. et al. Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 20, 57\u201367 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR71","doi-asserted-by":"publisher","first-page":"e30523","DOI":"10.1371\/journal.pone.0030523","volume":"7","author":"V Audard","year":"2012","unstructured":"Audard, V., Pawlak, A., Candelier, M., Lang, P. & Sahali, D. Upregulation of nuclear factor-related kappa B suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome. PLoS ONE 7, e30523 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneph2016147_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1523-1755.2004.00706.x","volume":"66","author":"DH Aviles","year":"2004","unstructured":"Aviles, D. H., Matti Vehaskari, V., Manning, J., Ochoa, A. C. & Zea, A. H. Decreased expression of T-cell NF-\u03baB p65 subunit in steroid-resistant nephrotic syndrome. Kidney Int. 66, 60\u201367 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR73","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","volume":"39","author":"G Lama","year":"2002","unstructured":"Lama, G. et al. T-Lymphocyte populations and cytokines in childhood nephrotic syndrome. Am. J. Kidney Dis. 39, 958\u2013965 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR74","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1681\/ASN.2006121346","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc, A. L. et al. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J. Am. Soc. Nephrol. 18, 2732\u20132739 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR75","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1542\/peds.2006-2164","volume":"119","author":"BG Hinkes","year":"2007","unstructured":"Hinkes, B. G. et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119, e907\u2013e919 (2007).","journal-title":"Pediatrics"},{"key":"BFnrneph2016147_CR76","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000182343","volume":"29","author":"H Autio-Harmainen","year":"1981","unstructured":"Autio-Harmainen, H. & Rapola, J. Renal pathology of fetuses with congenital nephrotic syndrome of the Finnish type. a qualitative and quantitative light microscopic study. Nephron 29, 158\u2013163 (1981).","journal-title":"Nephron"},{"key":"BFnrneph2016147_CR77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/73456","volume":"24","author":"JM Kaplan","year":"2000","unstructured":"Kaplan, J. M. et al. Mutations in ACTN4, encoding \u03b1-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24, 251\u2013256 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrneph2016147_CR78","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1106215","volume":"308","author":"MP Winn","year":"2005","unstructured":"Winn, M. P. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801\u20131804 (2005).","journal-title":"Science"},{"key":"BFnrneph2016147_CR79","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ng.505","volume":"42","author":"EJ Brown","year":"2010","unstructured":"Brown, E. J. et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42, 72\u201376 (2010).","journal-title":"Nat. Genet."},{"key":"BFnrneph2016147_CR80","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1681\/ASN.2013090976","volume":"25","author":"RA Gbadegesin","year":"2014","unstructured":"Gbadegesin, R. A. et al. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. J. Am. Soc. Nephrol. 25, 1991\u20132002 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR81","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ki.2014.48","volume":"85","author":"EJ Brown","year":"2014","unstructured":"Brown, E. J., Pollak, M. R. & Barua, M. Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int. 85, 1030\u20131038 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR82","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.05260610","volume":"6","author":"S Santin","year":"2011","unstructured":"Santin, S. et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 6, 1139\u20131148 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR83","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/ndt\/gfr771","volume":"27","author":"IM Rood","year":"2012","unstructured":"Rood, I. M., Deegens, J. K. & Wetzels, J. F. Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol. Dial. Transplant. 27, 882\u2013890 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR84","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski, C. E. et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279\u20131289 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR85","doi-asserted-by":"publisher","unstructured":"Karp, A. M. & Gbadegesin, R. A. Genetics of childhood steroid-sensitive nephrotic syndrome. Pediatr. Nephrol. http:\/\/dx.doi.org\/10.1007\/s00467-016-3456-8 (2016).","DOI":"10.1007\/s00467-016-3456-8"},{"key":"BFnrneph2016147_CR86","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ajhg.2014.04.010","volume":"94","author":"HY Gee","year":"2014","unstructured":"Gee, H. Y. et al. Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 94, 884\u2013890 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2016147_CR87","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1681\/ASN.2014121197","volume":"27","author":"X Wan","year":"2016","unstructured":"Wan, X. et al. Loss of epithelial membrane protein 2 aggravates podocyte injury via upregulation of caveolin-1. J. Am. Soc. Nephrol. 27, 1066\u20131075 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR88","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1681\/ASN.2014030247","volume":"26","author":"RA Gbadegesin","year":"2015","unstructured":"Gbadegesin, R. A. et al. HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1701\u20131710 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-065X.1998.tb01242.x","volume":"165","author":"AJ McAdam","year":"1998","unstructured":"McAdam, A. J., Schweitzer, A. N. & Sharpe, A. H. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol. Rev. 165, 231\u2013247 (1998).","journal-title":"Immunol. Rev."},{"key":"BFnrneph2016147_CR90","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin, E. H. et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int. 78, 296\u2013302 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR91","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00467-013-2679-1","volume":"29","author":"G Cara-Fuentes","year":"2014","unstructured":"Cara-Fuentes, G. et al. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr. Nephrol. 29, 1363\u20131371 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR92","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00467-014-2915-3","volume":"30","author":"C Ling","year":"2014","unstructured":"Ling, C. et al. Urinary CD80 levels as a diagnostic biomarker of minimal change disease. Pediatr. Nephrol. 30, 309\u2013316 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR93","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu, C. C. et al. Abatacept in B7-1-positive proteinuric kidney disease. N. Engl. J. Med. 369, 2416\u20132423 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2016147_CR94","doi-asserted-by":"publisher","first-page":"F335","DOI":"10.1152\/ajprenal.00510.2015","volume":"310","author":"R Novelli","year":"2016","unstructured":"Novelli, R., Gagliardini, E., Ruggiero, B., Benigni, A. & Remuzzi, G. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? Am. J. Physiol. Renal Physiol. 310, F335\u2013F341 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2016147_CR95","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1681\/ASN.2015091002","volume":"27","author":"M Delville","year":"2016","unstructured":"Delville, M. et al. B7-1 blockade does not improve post-transplant nephrotic syndrome caused by recurrent FSGS. J. Am. Soc. Nephrol. 27, 2520\u20132527 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR96","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1053\/j.ajkd.2014.07.023","volume":"64","author":"CP Larsen","year":"2014","unstructured":"Larsen, C. P., Messias, N. C. & Walker, P. D. B7-1 immunostaining in proteinuric kidney disease. Am. J. Kidney Dis. 64, 1001\u20131003 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2016147_CR97","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00467-014-2957-6","volume":"30","author":"EH Garin","year":"2015","unstructured":"Garin, E. H. et al. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr. Nephrol. 30, 469\u2013477 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1681\/ASN.V113403","volume":"11","author":"HM Regele","year":"2000","unstructured":"Regele, H. M. et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 11, 403\u2013412 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR99","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.2215\/CJN.01510209","volume":"4","author":"G Giannico","year":"2009","unstructured":"Giannico, G., Yang, H., Neilson, E. G. & Fogo, A. B. Dystroglycan in the diagnosis of FSGS. Clin. J. Am. Soc. Nephrol. 4, 1747\u20131753 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR100","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ndt\/gfp465","volume":"25","author":"NP Vogtlander","year":"2010","unstructured":"Vogtlander, N. P. et al. Expression of sialidase and dystroglycan in human glomerular diseases. Nephrol. Dial. Transplant. 25, 478\u2013484 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR101","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1097\/01.ASN.0000090745.85482.06","volume":"14","author":"H Schmid","year":"2003","unstructured":"Schmid, H. et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J. Am. Soc. Nephrol. 14, 2958\u20132966 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR102","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2353\/ajpath.2010.090746","volume":"177","author":"JB Hodgin","year":"2010","unstructured":"Hodgin, J. B. et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am. J. Pathol. 177, 1674\u20131686 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2016147_CR103","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrneph.2014.1","volume":"10","author":"SJ Shankland","year":"2014","unstructured":"Shankland, S. J., Smeets, B., Pippin, J. W. & Moeller, M. J. The emergence of the glomerular parietal epithelial cell. Nat. Rev. Nephrol. 10, 158\u2013173 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2016147_CR104","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1159\/000106775","volume":"107","author":"MR Bennett","year":"2007","unstructured":"Bennett, M. R. et al. Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp. Nephrol. 107, e30\u2013e40 (2007).","journal-title":"Nephron Exp. Nephrol."},{"key":"BFnrneph2016147_CR105","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1096\/fj.02-0125fje","volume":"16","author":"N Endlich","year":"2002","unstructured":"Endlich, N. et al. Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J. 16, 1850\u20131852 (2002).","journal-title":"FASEB J."},{"key":"BFnrneph2016147_CR106","doi-asserted-by":"publisher","first-page":"14063","DOI":"10.1074\/jbc.M707390200","volume":"283","author":"KP Hanley","year":"2008","unstructured":"Hanley, K. P. et al. Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J. Biol. Chem. 283, 14063\u201314071 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2016147_CR107","doi-asserted-by":"crossref","unstructured":"International Study of Kidney Disease in Children. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 13, 159\u2013165 (1978).","DOI":"10.1038\/ki.1978.23"},{"key":"BFnrneph2016147_CR108","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone, A. F. et al. Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int. 86, 1253\u20131259 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR109","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00005792-197309000-00008","volume":"52","author":"W Jao","year":"1973","unstructured":"Jao, W., Pollak, V. E., Norris, S. H., Lewy, P. & Pirani, C. L. Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes. Medicine (Baltimore) 52, 445\u2013468 (1973).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph2016147_CR110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ki.1990.175","volume":"38","author":"A Fogo","year":"1990","unstructured":"Fogo, A. et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int. 38, 115\u2013123 (1990).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR111","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF00866336","volume":"8","author":"E Nyberg","year":"1994","unstructured":"Nyberg, E., Bohman, S. O. & Berg, U. Glomerular volume and renal function in children with different types of the nephrotic syndrome. Pediatr. Nephrol. 8, 285\u2013289 (1994).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR112","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/BF00856517","volume":"8","author":"J Suzuki","year":"1994","unstructured":"Suzuki, J., Yoshikawa, N. & Nakamura, H. A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis. Pediatr. Nephrol. 8, 416\u2013419 (1994).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2016147_CR113","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2215\/CJN.04680709","volume":"5","author":"N Tsuboi","year":"2010","unstructured":"Tsuboi, N. et al. Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy. Clin. J. Am. Soc. Nephrol. 5, 39\u201344 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR114","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1681\/ASN.2014070641","volume":"26","author":"VG Puelles","year":"2015","unstructured":"Puelles, V. G. et al. Podocyte number in children and adults: associations with glomerular size and numbers of other glomerular resident cells. J. Am. Soc. Nephrol. 26, 2277\u20132288 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR115","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(66)92539-6","volume":"2","author":"JS Cameron","year":"1966","unstructured":"Cameron, J. S. & Blandford, G. The simple assessment of selectivity in heavy proteinuria. Lancet 2, 242\u2013247 (1966).","journal-title":"Lancet"},{"key":"BFnrneph2016147_CR116","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10157-013-0814-8","volume":"18","author":"K Hanamura","year":"2014","unstructured":"Hanamura, K., Tojo, A. & Fujita, T. Urinary and glomerular podocytes in patients with chronic kidney diseases. Clin. Exp. Nephrol. 18, 95\u2013103 (2014).","journal-title":"Clin. Exp. Nephrol."},{"key":"BFnrneph2016147_CR117","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1681\/ASN.2013020173","volume":"24","author":"L Wickman","year":"2013","unstructured":"Wickman, L. et al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J. Am. Soc. Nephrol. 24, 2081\u20132095 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR118","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","volume":"11","author":"SK Mak","year":"1996","unstructured":"Mak, S. K., Short, C. D. & Mallick, N. P. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol. Dial. Transplant. 11, 2192\u20132201 (1996).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2016147_CR119","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ki.1986.130","volume":"29","author":"F Nolasco","year":"1986","unstructured":"Nolasco, F. et al. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 29, 1215\u20131223 (1986).","journal-title":"Kidney Int."},{"key":"BFnrneph2016147_CR120","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman, M. et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin. J. Am. Soc. Nephrol. 2, 445\u2013453 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR121","first-page":"213","volume":"10","author":"JS Cameron","year":"1978","unstructured":"Cameron, J. S. The long term prognosis of patients with focal glomerulosclerosis. Clin. Nephrol. 10, 213\u2013229 (1978).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2016147_CR122","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000181374","volume":"21","author":"H Beaufils","year":"1978","unstructured":"Beaufils, H., Alphonse, J. C., Guedon, J. & Legrain, M. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 21, 75\u201385 (1978).","journal-title":"Nephron"},{"key":"BFnrneph2016147_CR123","first-page":"53","volume":"36","author":"G Banfi","year":"1991","unstructured":"Banfi, G. et al. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin. Nephrol. 36, 53\u201359 (1991).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2016147_CR124","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. 2 (Suppl.), 139\u2013274 (2012)."},{"key":"BFnrneph2016147_CR125","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1681\/ASN.2013080852","volume":"25","author":"WY Ding","year":"2014","unstructured":"Ding, W. Y. et al. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J. Am. Soc. Nephrol. 25, 1342\u20131348 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR126","first-page":"18","volume":"97","author":"CH Coggins","year":"1986","unstructured":"Coggins, C. H. Adult minimal change nephropathy: experience of the collaborative study of glomerular disease. Trans. Am. Clin. Climatol. Assoc. 97, 18\u201326 (1986).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"BFnrneph2016147_CR127","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1681\/ASN.2010090963","volume":"22","author":"T Matsusaka","year":"2011","unstructured":"Matsusaka, T. et al. Podocyte injury damages other podocytes. J. Am. Soc. Nephrol. 22, 1275\u20131285 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2016147_CR128","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1681\/ASN.2013080859","volume":"25","author":"M Venkatareddy","year":"2014","unstructured":"Venkatareddy, M. et al. Estimating podocyte number and density using a single histologic section. J. Am. Soc. Nephrol. 25, 1118\u20131129 (2014).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2016.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2016.147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2016.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:48:14Z","timestamp":1684471694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2016.147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":128,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFnrneph2016147"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2016.147","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]},"assertion":[{"value":"17 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}